Published in:
01-05-2019 | Positron Emission Tomography | Short Communication
Effect of (Z)-isomer content on [11C]ABP688 binding potential in humans
Authors:
Kelly Smart, Sylvia M. L. Cox, Alexey Kostikov, Aliaksandr Shalai, Stephanie G. Scala, Maria Tippler, Natalia Jaworska, Michel Boivin, Jean R. Séguin, Chawki Benkelfat, Marco Leyton
Published in:
European Journal of Nuclear Medicine and Molecular Imaging
|
Issue 5/2019
Login to get access
Abstract
Purpose
To determine how the low-affinity (Z)-isomer of the radiotracer [11C]ABP688 affects binding potential values in vivo in humans.
Methods
High-resolution [11C]ABP688 PET scans were acquired on 74 healthy volunteers (25 male, 49 female, mean age 20 ± 3.0). The relative contents of (E)- and (Z)-isomers were determined prior to injection using analytical high-performance liquid chromatography [rt(E) = 10 min, rt(Z) = 8.5 min]. Mean binding potential [BPND = fND * (Bavail/KD)] values were calculated in the striatum, limbic regions, and prefrontal cortex using the simplified reference tissue model with cerebellar grey matter as reference.
Results
Mean ± SD (E)-isomer content in [11C]ABP688 production was 92 ± 3.8% (range 78–97%). Percent (E)-isomer was positively correlated with BPND in the striatum (ρ = 0.28, p = 0.015) and limbic regions (ρ = 0.25, p = 0.036). In multiple regression analysis, sex (β = 0.39, p = 0.001) and (E)-isomer content (β = 0.23, p = 0.040) were significant predictors of BPND.
Conclusions
Even modest levels of (Z)-[11C]ABP688 can reduce estimates of tracer binding in vivo. Future studies should use production methods that enrich levels of (E)-[11C]ABP688, report tracer isomer ratios, and account for this factor in their analyses.